ME News reports that on August 4 (UTC+8), Andrei Grachev, co-founder of DWF Labs, responded to recent market speculation regarding DEXE trades, stating that all related transactions can be verified through centralized exchange records. Grachev outlined DWF Labs’ DEXE trading process as follows: substantial purchases of DEXE in 2024, partial sales for profit in 2025, another large purchase of DEXE around October 10, hedging gains in the first half of 2026, being forced to close short positions after funding rates turned negative, and increasing cash reserves by selling a portion of DEXE spot holdings. Grachev emphasized that all buy and sell operations were executed through centralized exchanges, which hold the relevant account data, and criticized certain paid KOLs for spreading misleading information. (Source: ChainCatcher)
DWF Labs Co-Founder Explains DEXE Trading Activities Amid Short-Selling Speculation
KuCoinFlashShare
DWF Labs co-founder Andrei Grachev addressed recent speculation surrounding DEXE trading, highlighting a favorable risk-to-reward ratio in all actions. He confirmed that all transactions took place on centralized exchanges and are verifiable. Grachev outlined a bulk purchase in 2024, profit-taking in 2025, a second purchase on October 10, 2025, hedging in early 2026, and forced short liquidation due to negative funding rates. He also criticized paid KOLs for disseminating false narratives, urging investors to focus on value investing in crypto fundamentals.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.